drugset / Trial / NCT03994380
Use of DNAse in Neutrophilic Asthma
NaSingle-groupOpen-labelTreatment
Summary
In this pilot protocol, the researchers look to determine benefits from use of nebulized rh-DNase for 4 weeks in patients with neutrophilic asthma.
Timeline
- Start
- 2020-02-12
- Primary completion
- 2022-05-31
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rhDNAse | Protein / enzyme biologic | 2.5 mg | Inhaled |